✦ LIBER ✦

Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine

✍ Scribed by Pierre Alberto; Kurt W. Brunner; Georg Martz; Jean-Paul Obrecht; Roland W. Sonntag

Publisher: John Wiley and Sons
Year: 1976
Tongue: English
Weight: 656 KB
Volume: 38
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197612)38:6<2208::aid-cncr2820380603>3.0.co;2-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oat cell carcinoma of the lung. Combinat

Oat cell carcinoma of the lung. Combination treatment with radiotherapy and cyclophosphamide, adriamycin, vincristine, and methotrexate

✍ Robert E. Wittes; Seymour Hopfan; Basil Hilaris; Robert B. Golbey; Myron Melamed 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 551 KB

Combination chemotherapy with methotrexa

Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck

✍ M. Clavel; F. Cognetti; P. Dodion; J. Wildiers; R. Rosso; A. Rossi; B. Gignoux; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 2 views

## For the EORTC Head and Neck Cooperative Group A total of 185 eligible patients with advanced inoperable squamous cell carcinoma of the head and neck were randomized into two groups; the cisplatin, methotrexate, bleomycin, and vincristine (CABO) group received cisplatin (50 mg/m2; day 4), methot

Combined chemotherapy with carmustine, d

Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma : A long-term follow-up study

✍ Luigi Rigacci; Valentina Carrai; Luca Nassi; Renato Alterini; Giovanni Longo; Fr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

Acquired immunodeficiency syndrome-relat

Acquired immunodeficiency syndrome-related lymphoma : Simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival—Results of the German Multicenter Trial

✍ Rudolf Weiss; Paris Mitrou; Keikawus Arasteh; Dirk Schuermann; Marcus Hentrich; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views